Noble Wealth Management PBC’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$723K Buy
603
+389
+182% +$397K 0.32% 82
2026
Q1
$197K Buy
214
+18
+9% +$18.2K 0.1% 145
2025
Q4
$211K Hold
196
0.11% 142
2025
Q3
$150K Buy
+196
New +$146K 0.08% 158
2025
Q1
$162K Hold
196
0.11% 134
2024
Q4
$151K Buy
+196
New +$162K 0.11% 133

Other funds holding LLY

Noble Wealth Management PBC's LLY Position: Q2 2026 in Review

Noble Wealth Management PBC increased its Eli Lilly (LLY) stake by 182% in Q2 2026, buying an estimated $397K and bringing the position to 603 shares worth $723K. The position accounts for 0.32% of the portfolio, ranked #82.

Noble Wealth Management PBC first reported a position in LLY in Q4 2024 and has held it in 6 quarters since. 2,244 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Noble Wealth Management PBC held 603 shares of Eli Lilly worth $723K as of Q2 2026.
  • Noble Wealth Management PBC bought 389 Eli Lilly shares in Q2 2026, an estimated $397K.
  • Eli Lilly made up 0.32% of Noble Wealth Management PBC's portfolio in Q2 2026, its #82 holding.
  • Noble Wealth Management PBC first reported a position in Eli Lilly in Q4 2024 and has held it in 6 quarters since.
  • 2,244 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Noble Wealth Management PBC's 13F filing for Q2 2026, filed 1 Jul 2026.